ATG13 and myalgic encephalomeyelitis/chronic fatigue syndrome: However, no significant correlation was observed between pSer258-ATG13 downregulation and alleviated fatigue symptoms in the viral-onset ME/CFS group, mainly because of a dramatic decrease in pSer258-ATG13 at the T3 stage.